Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5151–5200 of 18639
The Company’s board of directors intends to appoint J. Scott Wolchko, the Company’s President and Chief Executive Officer, to succeed Mr. Dulac as the Company’s Chief Financial Officer and also serve as the Company’s principal financial and accounting officer, effective immediately after Mr. Dulac’s resignation.
On May 30, 2024, Edward J. Dulac III provided notice of his resignation from his position as Chief Financial Officer of Fate Therapeutics, Inc. (the “Company”), which will be effective June 14, 2024.
On May 31, 2024, Anthony R. Corpora stepped down as the chief executive officer and a board member of US Lighting Group, Inc.
On May 29, 2024, Philip R. Mays, age 56, was appointed Senior Vice President, Chief Financial Officer and Treasurer of CTO Realty Growth, Inc. (the “Company”), effective as of June 17, 2024.
Mr. Paul Lytle, EVP, Chief Financial Officer of the Company, agreed to amend Mr. Lytle’s employment terms from full time status to part time status, not to exceed eight (8) hours per month effective June 1, 2024
announced that it has appointed Jennifer Gerold as the Company’s Chief Financial Officer
Ms. Gerold replaces Steven Gargano who served the Company as CFO since 2020.
The Company expects to name Mr. André as Chief Financial Officer on or about August 5, 2024.
Mr. Larson will step down from the role of Chief Financial Officer effective on or about August 5, 2024
following Ms. Marina Wolfson’s return from maternity leave
Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude
John Dolan, age 56, who has served as the Company’s senior vice president, chief accounting officer since May 2022, will succeed Mr. Stelben as the Company’s senior vice president, chief financial officer, effective August 31, 2024.
On May 29, 2024, John Stelben notified eHealth, Inc. (the “Company”) of his decision to resign from his position as the Company’s senior vice president, chief financial officer, effective August 30, 2024.
Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date
Beth Boulerice will step down from her roles as Chief Financial Officer and Treasurer effective March 1, 2025.
Mr. Brunner will be appointed to succeed Ms. Boulerice as Chief Financial Officer and Treasurer effective March 1, 2025.
On May 23, 2024, Mr. Kevin Schubert and the Company entered into a General Release and Separation Agreement (the “Separation Agreement”) wherein Mr. Schubert resigned from his role as Chief Financial Officer of Rubicon Technologies, Inc. (the “Company”), effective June 1, 2024.
On May 23, 2024, the Company entered into an amendment to that certain Offer Letter Agreement (the “Amendment”) entered into between the Company and Mr. Grant Deans dated August 29, 2023, wherein the Company offered Mr. Deans the position of Interim Chief Financial Officer.
appointed Adarsh Parekh as the Company’s Chief Financial Officer and Executive Vice President, effective as of June 17, 2024
appointed Brendan P. O’Grady to serve as the Company’s Chief Executive Officer (and principal executive officer) and as a director.
As previously reported, Ms. Wadsten communicated her intention to the Company to retire as of June 3, 2024.
On May 23, 2024, the Board of Directors of Jackson Financial Inc. (the “Company”) appointed Don W. Cummings as the Company’s new Executive Vice President and Chief Financial Officer (“CFO”) beginning June 3, 2024.
On May 23, 2024, Photronics, Inc. (the “Company”) named Eric Rivera Chief Financial Officer.
On May 28, 2024, the Board of Directors of the general partner (the “General Partner”) of Black Stone Minerals, L.P. (the “Partnership”) and Evan Kiefer, Senior Vice President, Chief Financial Officer, and Treasurer of the General Partner, agreed that Mr. Kiefer would depart his current roles at the general partner effective May 28, 2024.
The Board of Directors has appointed Taylor DeWalch as Senior Vice President and Chief Financial Officer of the General Partner and Dawn Smajstrla as Treasurer of the General Partner, effective May 28, 2024.
Effective June 10, 2024 (the “Separation Date”), Christopher Krawtschuk will depart bluebird bio, Inc. (the “Company”) and cease serving as Chief Financial Officer and principal accounting officer.
On May 28, 2024, the Board of Directors (the “Board”) appointed O. James Sterling as Chief Financial Officer of the Company and designated Mr. Sterling as principal accounting officer, effective as of the date Mr. Sterling commences employment with the Company, which is expected to be June 10, 2024 (the “Transition Date”).
On February 27, 2024, Marathon announced that Dane E. Whitehead, Executive Vice President and Chief Financial Officer of Marathon had informed Marathon of his intention to retire from Marathon effective July 1, 2024. Marathon and Mr. Whitehead agreed to delay his departure and Mr. Whitehead will remain an Executive Vice President and Advisor to the CEO
Effective May 28, 2024, the Board of Directors of American Realty Investors, Inc. (the “ Company ” or the “ Issuer ” or “ ARL ”) appointed Erik L. Johnson, age 56, President and Chief Executive Officer of the Company.
Effective May 28, 2024, the Board of Directors of Income Opportunity Realty Investors, Inc. (the “ Company ” or the “ Issuer ” or “ IOR ”) appointed Erik L. Johnson, age 56, President and Chief Executive Officer of the Company.
the April 14, 2023 resignation of Bradley J. Muth, age 68, from the offices of President and Chief Executive Officer.
Effective May 28, 2024, the Board of Directors of Transcontinental Realty Investors, Inc. (the “ Company ” or the “ Issuer ” or “ TCI ”) appointed Erik L. Johnson, age 56, President and Chief Executive Officer of the Company.
Alton Lewis will retire from his role as President and Chief Executive Officer of First Guaranty Bancshares, Inc. and First Guaranty Bank. Mr. Lewis will continue to serve as Vice Chairman of the First Guaranty Bancshares, Inc. and First Guaranty Bank Board of Directors.
On May 24, 2024, Tom McKinlay, Chief Executive Officer of the Company, informed the Company he will retire as Chief Executive Officer of the Company, effective September 30, 2024.
On May 28, 2024, the Board appointed Paul Chang, the Company’s Global President, as the Co-Chief Executive Officer of the Company, effective immediately, with full power and authority of a Chief Executive Officer as prescribed in the Bylaws of the Company, to serve in such capacity until his successor is elected and qualified or until his earlier death, resignation, or removal
concurrently with such appointment, Mr. Michael Zacharski, who currently serves as the Company’s Chief Executive Officer, will become Co-Chief Executive Officer.
On May 21, 2024, Vikram Grover resigned his positions as CEO, Treasurer, Controller and Director but will remain CFO pending a transition to new management.
On May 20, 2024, we named Ryan Nguyen, an industry expert in Web3 platforms and cryptocurrencies, as CEO and Director.
As previously announced, effective April 30, 2024, Monica Diaz Brickell left AXIL Brands, Inc. (the “Company”), including her position as the Chief Financial Officer of the Company.
On May 23, 2024, Robert Enslin informed UiPath, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”) and from his position as Chief Executive Officer (“CEO”) of the Company, effective June 1, 2024
On May 29, 2024, the Board appointed Daniel Dines, the Company’s Founder, Chairman, and Chief Innovation Officer, as CEO, as of the Effective Date.
Glen Ives, currently the Chief Operating Officer of the Company, will become the new CEO, effective July 1, 2024.
Mark C. Fuller, President and Chief Executive Officer ("CEO") of Castellum, Inc. (the "Company") will be stepping down from those positions effective July 1, 2024 to pursue other interests.
Stephen D. Griffin, Senior Vice President and Chief Financial Officer of VSE Corporation (the “Company”), notified the Company of his decision to resign from his positions with the Company, effective May 29, 2024
appointed Tarang Sharma to serve as Interim Chief Financial Officer, effective May 27, 2024
On May 27, 2024, the board of directors (the “ Board ”) of the Company appointed Joel R. Jung as Interim Chief Financial Officer and designated Mr. Jung as the Company’s principal financial officer and principal accounting officer, effective as of May 28, 2024.
On May 24, 2024, O. James Sterling tendered his resignation from his position as the Chief Financial Officer of Renalytix plc (the “ Company ”).
On May 22, 2024, the Board appointed Mr. Kowieski, age 47, as Chief Financial Officer ("CFO") of Evoke Pharma, Inc. (the "Company") effective May 22, 2024.
On May 28, 2024, the Company also announced the appointment, effective immediately, of Susan Landi as the Company’s new Chief Financial Officer and Treasurer.
On May 28, 2024, Farmland Partners Inc. (the “Company”) announced that the Company and James Gilligan, the Company’s Chief Financial Officer and Treasurer, mutually agreed to separate.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.